Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Cytomegalovirus Infection

  Free Subscription

Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 6 articles:
HTML format

Single Articles

    September 2022
  1. HALPERN-COHEN V, Blumberg EA
    New Perspectives on Antimicrobial Agents: Maribavir.
    Antimicrob Agents Chemother. 2022;66:e0240521.
    PubMed     Abstract available

    August 2022
  2. ROYSTON L, Masouridi-Levrat S, Gotta V, Royston E, et al
    Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Antimicrob Agents Chemother. 2022;66:e0065722.
    PubMed     Abstract available

    June 2021
  3. ZARROUK K, Zhu X, Pham VD, Goyette N, et al
    Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.
    Antimicrob Agents Chemother. 2021;65:e0039021.
    PubMed     Abstract available

    February 2021
  4. NGUYEN T, Oualha M, Briand C, Bendavid M, et al
    Population Pharmacokinetics of Intravenous Ganciclovir and Oral Valganciclovir in a Pediatric Population To Optimize Dosing Regimens.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available

    December 2020
  5. SU H, Ye X, Freed DC, Li L, et al
    A potent bispecific neutralizing antibody targeting glycoprotein B and the gH/gL/pUL128/130/131 complex of human cytomegalovirus.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.02422.
    PubMed     Abstract available

    October 2020
  6. HAMILTON ST, Marschall M, Rawlinson WD
    Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01627.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.